drugset / Trial / NCT02908620

Experimental Pain Study to Assess Local Anesthetic Efficacy and Safety of CTY-5339 Anesthetic Spray in Normal Volunteers

NCT02908620

Phase 2 Completed 40 enrolled Cetylite Industries
RandomizedCrossoverDouble-blindPrevention

Summary

The purpose of this study is to determine if the topical application to cheek tissue of the combination of benzocaine and tetracaine has a longer duration of local anesthetic activity than benzocaine alone.

Timeline

Start
2016-12-07
Primary completion
2017-04-02
Completion
2017-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzocaine Small molecule 28 mg Topical
Subject Benzocaine Small molecule 56 mg Topical
Subject tetracaine Other / unclassified 4 mg Topical
Subject tetracaine Other / unclassified 8 mg Topical

Indications

No indication recorded.